Healthcare
0
Risk Adjustment and Incentives for Upcoding in Medicare – Healthcare Economist
0

To account for differences in disease burden among the patient population of Medicare Advantage (MA) plans, risk adjustment based on the patient's disease ...

0
HHS Office for Civil Rights Creates FAQ Webpage in Response to the Change Healthcare Cyberattack
0

Today, the U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) published a new webpage to share answers to frequently ...

0
What would happen if we eliminated medical debt? – Healthcare Economist
0

Medical debt in the United States is a major problem. While more than 90% of people have health insurance, many people ...

0
FDA’s Biosimilars Action Plan – Healthcare Economist
0

In July 2018, the FDA published the Biosimilars Action Plan (BAP), which outlined the FDA's approach to expanding access ...

0
Do patients value improvements in progression-free survival? – Healthcare Economist
0

Progression-free survival (PFS) is a surrogate endpoint defined as follows (by ChatGPT): Essentially, PFS refers to the period of time during a ...

0
EMA and delays in drug launch – Healthcare Economist
0

For patients with serious illnesses, timely access to effective medications is paramount. The European Medicines Agency (EMA) was created in part to help ...

0
Cross-country comparison in health care price growth: 2000-2020 – Healthcare Economist
0

How have health care prices changed over the past two decades? That is the question of an article by Pap smears (2024) aims to answer, comparing US prices ...

0
An overview – Healthcare Economist
0

an article of Kogut (2024) has a good overview of organizations that develop pharmacy plan quality metrics. The quality of pharmacy plans is vital as ...

0
Considerations in payer coverage of digital therapeutics – Healthcare Economist
0

The Digital Therapeutics Alliance defines a digital therapeutics (DTx) as “evidence-based therapeutic interventions ...

0
Daniel Kahneman – Healthcare Economist
0

Today Nobel Prize winner Daniel Kahneman passed away. His work incorporates psychology into economics through Possible theory It has been a great advance. ...

Tools4BLS
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart